Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company’s AI-enabled Drug Development Strategy PHILADELPHIA, PA / ACCESS Newswire / March 10, 2026 / ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

The East City Precinct, situated between Cape Town’s parliamentary buildings and District Six, is lined with restaurants, cafés, museums, and trendy spaces for both day and night exploration.